Case study · Healthcare & Life Sciences
Supplier-side primary research that caught a channel shift the trade press hadn't reported.
A Fortune 500 medical devices company avoided a Q3 delivery gap after our sourcing team caught a supplier consolidation risk twelve weeks early.
-
The client's category sourcing team had received a routine price-increase letter from their primary supplier. Something in the wording suggested a bigger structural shift underneath. They needed an independent read on whether the supplier was about to consolidate its channel — and how much of their category spend was at risk.
-
A senior lead ran a targeted supplier-side primary program across seven suppliers in adjacent categories. Two domain analysts assembled channel-level shipment data from customs filings. We identified a consolidation move that had not yet been reported in the trade press — the primary supplier had quietly acquired a distribution network in the client's largest region.
-
A 26-page memo with the supplier map, the channel-shift narrative, a shortlist of three second-source suppliers we had validated as production-ready, and a suggested split of category spend across primary and secondary sources.
-
The client updated their sourcing strategy inside a quarter. They moved 18% of category spend to a second-source supplier and avoided a Q3 delivery gap that would otherwise have hit their production line. Category sourcing lead named the engagement in their internal EOY review.
Client identity is anonymised in this write-up. On-record versions are available on request where the client has given explicit consent — reach the desk for named references.
Similar decision on your table?
Let's scope the research that supports it.
A 30-minute scoping call is free. We'll tell you honestly whether an existing report answers your question, or whether it warrants a custom engagement like this one.